Malcolm Lloyd Smith Neurocrine Biosciences Inc (NBIX) insider trading activity

Malcolm Lloyd Smith is Chief Integration Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 42,337 shares of NBIX, which is worth approximately $5.89 Million. The most recent transaction as insider was on Feb 08, 2023, when has been sold 701 shares (Common Stock) at a price of $103.83 per share, resulting in proceeds of $72,784. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.3K

0% 3M change

0% 12M change

Total Value Held $5.89 Million

Malcolm Lloyd-Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2023	SELL Open market or private sale	$72,784 $103.83 p/Share	701 Reduced 1.63%	42,337 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,413,238 $102.29 p/Share	13,816 Reduced 24.88%	41,710 Common Stock
Feb 06 2023	SELL Open market or private sale	$84,761 $105.82 p/Share	801 Reduced 2.66%	29,300 Common Stock
Jan 31 2023	SELL Open market or private sale	$183,293 $110.02 p/Share	1,666 Reduced 5.51%	28,582 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$430,864 $53.57 p/Share	8,043 Added 23.0%	26,931 Common Stock
Aug 12 2022	SELL Open market or private sale	$2,281,421 $105.95 p/Share	21,533 Reduced 53.27%	18,888 Common Stock
Aug 12 2022	BUY Exercise of conversion of derivative security	$774,973 $35.99 p/Share	21,533 Added 34.76%	40,421 Common Stock
Feb 08 2022	SELL Open market or private sale	$55,751 $79.53 p/Share	701 Reduced 3.61%	18,731 Common Stock
Feb 07 2022	SELL Open market or private sale	$216,410 $80.72 p/Share	2,681 Reduced 12.9%	18,104 Common Stock
Jul 27 2021	SELL Open market or private sale	$1,567,304 $93.8 p/Share	16,709 Reduced 51.4%	15,801 Common Stock
Feb 10 2021	SELL Open market or private sale	$203,915 $119.95 p/Share	1,700 Reduced 4.97%	32,510 Common Stock
Feb 10 2021	BUY Exercise of conversion of derivative security	$61,183 $35.99 p/Share	1,700 Added 4.88%	33,110 Common Stock
Feb 08 2021	SELL Open market or private sale	$380,983 $116.83 p/Share	3,261 Reduced 9.12%	32,510 Common Stock
Feb 05 2021	SELL Open market or private sale	$98,740 $114.15 p/Share	865 Reduced 2.83%	29,675 Common Stock
Jan 26 2021	SELL Open market or private sale	$131,967 $119.97 p/Share	1,100 Reduced 3.65%	29,002 Common Stock
Jan 26 2021	BUY Exercise of conversion of derivative security	$39,589 $35.99 p/Share	1,100 Added 3.58%	29,602 Common Stock
Jan 25 2021	SELL Open market or private sale	$2,107,873 $119.97 p/Share	17,570 Reduced 37.73%	29,002 Common Stock
Jan 25 2021	BUY Exercise of conversion of derivative security	$614,774 $34.99 p/Share	17,570 Added 31.64%	37,960 Common Stock
Nov 12 2020	SELL Open market or private sale	$204,778 $90.73 p/Share	2,257 Reduced 7.22%	29,002 Common Stock

Malcolm Lloyd Smith

Chief Integration Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account